Positron emission tomography in Parkinson's disease: glucose and DOPA metabolism. 1987

W R Martin, and A J Stoessl, and M J Adam, and W Ammann, and M Bergstrom, and R Harrop, and A Laihinen, and J G Rogers, and T J Ruth, and C I Sayre

UI MeSH Term Description Entries
D007980 Levodopa The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system. L-Dopa,3-Hydroxy-L-tyrosine,Dopaflex,Dopar,L-3,4-Dihydroxyphenylalanine,Larodopa,Levopa,3 Hydroxy L tyrosine,L 3,4 Dihydroxyphenylalanine,L Dopa
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D011699 Putamen The largest and most lateral of the BASAL GANGLIA lying between the lateral medullary lamina of the GLOBUS PALLIDUS and the EXTERNAL CAPSULE. It is part of the neostriatum and forms part of the LENTIFORM NUCLEUS along with the GLOBUS PALLIDUS. Nucleus Putamen,Nucleus Putamens,Putamen, Nucleus,Putamens,Putamens, Nucleus
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002421 Caudate Nucleus Elongated gray mass of the neostriatum located adjacent to the lateral ventricle of the brain. Caudatus,Nucleus Caudatus,Caudatus, Nucleus,Nucleus, Caudate
D002531 Cerebellum The part of brain that lies behind the BRAIN STEM in the posterior base of skull (CRANIAL FOSSA, POSTERIOR). It is also known as the "little brain" with convolutions similar to those of CEREBRAL CORTEX, inner white matter, and deep cerebellar nuclei. Its function is to coordinate voluntary movements, maintain balance, and learn motor skills. Cerebella,Corpus Cerebelli,Parencephalon,Cerebellums,Parencephalons
D003847 Deoxyglucose 2-Deoxy-D-arabino-hexose. An antimetabolite of glucose with antiviral activity. 2-Deoxy-D-glucose,2-Deoxyglucose,2-Desoxy-D-glucose,2 Deoxy D glucose,2 Deoxyglucose,2 Desoxy D glucose
D004295 Dihydroxyphenylalanine A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific. Dopa,3,4-Dihydroxyphenylalanine,3-Hydroxy-DL-tyrosine,Dihydroxyphenylalanine Hydrochloride, (2:1),beta-Hydroxytyrosine,3 Hydroxy DL tyrosine,3,4 Dihydroxyphenylalanine,beta Hydroxytyrosine

Related Publications

W R Martin, and A J Stoessl, and M J Adam, and W Ammann, and M Bergstrom, and R Harrop, and A Laihinen, and J G Rogers, and T J Ruth, and C I Sayre
October 1992, Neurology,
W R Martin, and A J Stoessl, and M J Adam, and W Ammann, and M Bergstrom, and R Harrop, and A Laihinen, and J G Rogers, and T J Ruth, and C I Sayre
January 1999, Advances in neurology,
W R Martin, and A J Stoessl, and M J Adam, and W Ammann, and M Bergstrom, and R Harrop, and A Laihinen, and J G Rogers, and T J Ruth, and C I Sayre
February 1992, The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques,
W R Martin, and A J Stoessl, and M J Adam, and W Ammann, and M Bergstrom, and R Harrop, and A Laihinen, and J G Rogers, and T J Ruth, and C I Sayre
December 1999, Pediatrics international : official journal of the Japan Pediatric Society,
W R Martin, and A J Stoessl, and M J Adam, and W Ammann, and M Bergstrom, and R Harrop, and A Laihinen, and J G Rogers, and T J Ruth, and C I Sayre
August 2011, American journal of translational research,
W R Martin, and A J Stoessl, and M J Adam, and W Ammann, and M Bergstrom, and R Harrop, and A Laihinen, and J G Rogers, and T J Ruth, and C I Sayre
January 2007, Parkinsonism & related disorders,
W R Martin, and A J Stoessl, and M J Adam, and W Ammann, and M Bergstrom, and R Harrop, and A Laihinen, and J G Rogers, and T J Ruth, and C I Sayre
February 1997, Annals of neurology,
W R Martin, and A J Stoessl, and M J Adam, and W Ammann, and M Bergstrom, and R Harrop, and A Laihinen, and J G Rogers, and T J Ruth, and C I Sayre
April 1988, Psychiatry research,
W R Martin, and A J Stoessl, and M J Adam, and W Ammann, and M Bergstrom, and R Harrop, and A Laihinen, and J G Rogers, and T J Ruth, and C I Sayre
July 1991, Annals of neurology,
W R Martin, and A J Stoessl, and M J Adam, and W Ammann, and M Bergstrom, and R Harrop, and A Laihinen, and J G Rogers, and T J Ruth, and C I Sayre
January 1995, The Journal of neuropsychiatry and clinical neurosciences,
Copied contents to your clipboard!